[Chronic lympholeukemia. I. Clinical variants].
Ludmila Popova, P Apostolov, S Vlaĭkova, Ts Stamenova
Abstract
Ludmila Popova, P Apostolov, S Vlaĭkova, Ts Stamenova
Abstract
The study includes 133 patients with chronic lymphatic leukemia treated by the authors for a five year period (1980-1984). Data from the patients' history, status, blood picture, treatment and therapeutic efficacy are taken into consideration. The importance of splenomegaly is emphasized. Four clinical variants are differentiated: I. calm lymphatic leukemia; 2. secondary splenomegalic lymphatic leukemia; 3. primary splenomegalic lymphatic leukemia; 4. pure splenomegalic lymphatic leukemia. The study is supported by cytologic and immunologic investigations. This allows precision of the prognosis and of the therapeutic conduct.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The study includes 133 patients with chronic lymphatic leukemia treated by the authors for a five year period (1980-1984). Data from the patients' history, status, blood picture, treatment and therapeutic efficacy are taken into consideration. The importance of splenomegaly is emphasized. Four clinical variants are differentiated: I. calm lymphatic leukemia; 2. secondary splenomegalic lymphatic leukemia; 3. primary splenomegalic lymphatic leukemia; 4. pure splenomegalic lymphatic leukemia. The study is supported by cytologic and immunologic investigations. This allows precision of the prognosis and of the therapeutic conduct.
Key concepts: Chronic lymphatic leukemia, Lymphatic system, Leukemia, Medicine, Lymphatic leukemia, Chronic leukemia, Pathology, Oncology